Pfizer Inc. agreed to delay implementation of planned price increases for certain drugs a day after President Donald Trump launched an attack on the company.
Trump's recent drug plan suggested looking at whether benefit managers should be considered fiduciaries, which would force them to put their customers' financial interests ahead of their own.
While Martin Shkreli became notorious for sharply increasing drug prices, this duo has quietly plied their trade helping to kick-start drug company sales.
Purdue Pharma's decision to stop promoting its opioid drugs is being hailed as the first result of a judge's push for concrete solutions to a nationwide epidemic.
Pain-pill giant Purdue Pharma LP plans to send a letter to doctors saying that its salespeople will no longer come to their clinics to talk about the companys pain products.
U.S. District Judge Daniel Polster summoned pharma executives, law enforcement, government officials and lawyers to his court on Wednesday to forge a deal that would address the crisis and resolve more than 200 lawsuits
DebugScreen: mobile
{
"author": {
"name": "Jared S Hopkins",
"webUrl": "/author/profile/jared-s-hopkins/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 19,
"social": [],
"articles": [
{
"uri": "/2018/10/30/small-hospitals-band-together-to-cash-in-on-drug-t/",
"title": "Small hospitals band together to cash in on drug trials",
"byline": "Jared S. Hopkins",
"kicker": "News",
"prettyDate": "October 30, 2018",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/HospitalER.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S. Hopkins"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Drugmakers are constantly searching for patients for clinical trials and pay hospitals handsomely to test their medicines.",
"body": null
},
{
"uri": "/2018/09/14/purdues-latest-damage-control-offer-free-opioid-ad/",
"title": "Purdue's latest damage-control offer: free opioid-addiction drug",
"byline": "Jared S Hopkins and Jef Feeley",
"kicker": "News",
"prettyDate": "September 14, 2018",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/opioid-abuse-crop.jpg",
"width": "600",
"height": "338"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
},
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The offer is the latest in the OxyContin maker's attempt to resolve more than 1,000 lawsuits accusing Purdue of helping fuel the opioid crisis.",
"body": null
},
{
"uri": "/2018/08/01/pfizer-ceo-predicts-an-end-to-drug-rebates/",
"title": "Pfizer CEO predicts an end to drug rebates",
"byline": "Jared S Hopkins",
"kicker": "News",
"prettyDate": "August 01, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/08/IanReadBloomberg.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "“We're going to go to a marketplace where we don't have rebates,” Pfizer's Ian Read told analysts.",
"body": null
},
{
"uri": "/2018/07/24/purdue-brings-in-turnaround-kid-to-overhaul-image/",
"title": "Purdue brings in \"Turnaround Kid\" to overhaul image",
"byline": "Jared S Hopkins and Sonali Basak",
"kicker": "News",
"prettyDate": "July 24, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/OpioidsNationally.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
},
{
"webUrl": "/author/profile/sonali-basak/",
"name": "Sonali Basak"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The move comes as the Oxycontin maker tries to overhaul its business and distance itself from the U.S. opioid crisis.",
"body": null
},
{
"uri": "/2018/07/11/caving-to-pressure-pfizer-delays-price-hikes/",
"title": "Caving to pressure, Pfizer delays price hikes",
"byline": "Jared S Hopkins and Toluse Olorunnipa",
"kicker": "News",
"prettyDate": "July 11, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/Pfizer.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
},
{
"webUrl": "/author/profile/toluse-olorunnipa/",
"name": "Toluse Olorunnipa"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Pfizer Inc. agreed to delay implementation of planned price increases for certain drugs a day after President Donald Trump launched an attack on the company.",
"body": null
},
{
"uri": "/2018/05/17/fiduciary-rule-revival-should-it-apply-to-pharmacy/",
"title": "Fiduciary rule revival: Should it apply to pharmacy benefits managers?",
"byline": "Jared S Hopkins",
"kicker": "News",
"prettyDate": "May 17, 2018",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/MoneyVsPills.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Trump's recent drug plan suggested looking at whether benefit managers should be considered fiduciaries, which would force them to put their customers' financial interests ahead of their own.",
"body": null
},
{
"uri": "/2018/04/10/the-duo-quietly-helping-pharmacy-companies-raise-p/",
"title": "The duo quietly helping pharmacy companies raise prices",
"byline": "Jared S Hopkins and Andrew Martin",
"kicker": "Investigation",
"prettyDate": "April 10, 2018",
"timeToRead": "12 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/RisingHealthCosts.jpg",
"width": "600",
"height": "385"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
},
{
"webUrl": "/author/profile/andrew-martin/",
"name": "Andrew Martin"
}
],
"kickerNode": [
{
"uri": "/investigation/",
"sectionName": "Investigation"
}
],
"summary": "While Martin Shkreli became notorious for sharply increasing drug prices, this duo has quietly plied their trade helping to kick-start drug company sales.",
"body": null
},
{
"uri": "/2018/03/07/opioid-settlement-talks-heat-up-drugmakers-reduce/",
"title": "Opioid settlement talks heat up, drugmakers reduce marketing",
"byline": "Jef Feeley and Jared S Hopkins",
"kicker": "News",
"prettyDate": "March 07, 2018",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/OpioidsNationally.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley/",
"name": "Jef Feeley"
},
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Purdue Pharma's decision to stop promoting its opioid drugs is being hailed as the first result of a judge's push for concrete solutions to a nationwide epidemic.",
"body": null
},
{
"uri": "/2018/02/12/purdue-pharma-to-stop-promotion-of-opioids-to-doct/",
"title": "Purdue Pharma to stop promotion of opioids to doctors",
"byline": " Jared S. Hopkins ",
"kicker": "",
"prettyDate": "February 12, 2018",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "Pain-pill giant Purdue Pharma LP plans to send a letter to doctors saying that its salespeople will no longer come to their clinics to talk about the companys pain products.",
"body": null
},
{
"uri": "/2018/02/01/the-judge-singlehandedly-trying-to-solve-the-opioi/",
"title": "The judge singlehandedly trying to solve the opioid crisis",
"byline": " Jef Feeley, Jared S. Hopkins ",
"kicker": "",
"prettyDate": "February 01, 2018",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jef-feeley-jared-s-hopkins/",
"name": "Jef Feeley, Jared S. Hopkins"
}
],
"kickerNode": [],
"summary": "U.S. District Judge Daniel Polster summoned pharma executives, law enforcement, government officials and lawyers to his court on Wednesday to forge a deal that would address the crisis and resolve more than 200 lawsuits",
"body": null
}
]
}
}
